Renal transplantation in adolescents

Adolescent Medicine Clinics

Volumn 16, Issue 1, 2005, Pages 201-214

  Smith, Jodi M ^a   McDonald, Ruth A ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; BASILIXIMAB; CHICKENPOX VACCINE; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; DIPHENHYDRAMINE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOBLAST ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PARACETAMOL; PREDNISONE; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ACNE; ACUTE GRAFT REJECTION; ADOLESCENT; ALOPECIA; ANAPHYLAXIS; ARTHRALGIA; ASEPTIC NECROSIS; BONE MARROW SUPPRESSION; BRONCHOSPASM; BULIMIA; CANCER SUSCEPTIBILITY; CATARACT; CHILL; CLINICAL TRIAL; CUSHINGOID SYNDROME; DELAYED PUBERTY; DIALYSIS; DIARRHEA; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSPNEA; FLUID RETENTION; GINGIVA HYPERPLASIA; GLUCOSE INTOLERANCE; GRAFT SURVIVAL; GROWTH RETARDATION; HEART FAILURE; HIGH RISK PATIENT; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; INSOMNIA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER TOXICITY; LUNG EDEMA; LYMPHOPROLIFERATIVE DISEASE; MANIA; MEGALOBLASTIC ANEMIA; MENTAL INSTABILITY; NAUSEA; NEOPLASM; NEPHROTOXICITY; NONHUMAN; OBESITY; OSTEOPOROSIS; PANCREATITIS; PATIENT COMPLIANCE; PREOPERATIVE EVALUATION; PSYCHOSIS; QUALITY OF LIFE; RASH; RESPIRATORY FAILURE; REVIEW; STOMACH ULCER; SURVIVAL RATE; TACHYCARDIA; THROMBOCYTOPENIA; VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; QUALITY OF LIFE; RECOMBINANT FUSION PROTEINS;

EID: 10944272018     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.09.003     Document Type: Review

References (66)

1. R. McDonald, P.L. Ho, and D.M. Stablein Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Am J Transplant 1 2001 55 60
2. R. McDonald, L. Donaldson, and L. Emmett A decade of living donor transplantation in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Pediatr Transplant 4 2000 221 234
3. I. Elshihabi, B. Chavers, and L. Donaldson Continuing improvement in cadaver donor graft survival in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Pediatr Transplant 4 2000 235 246
4. M. Ishitani, R. Isaaca, and V. Norwood Predictors of graft survival in pediatric living-related kidney transplant recipients Transplantation 70 2000 288 292
5. J.M. Cecka, D.W. Gjertson, and P.I. Terasaki Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing Pediatr Transplant 1 1997 55 64
6. L.M. Foulkes, S.R. Boggs, and R.S. Fennell Social support, family variables, and compliance in renal transplant children Pediatr Nephrol 7 1993 185 188
7. North American Pediatric Renal Transplant Cooperative Study. 2003 Annual Report.
8. J.T. Mayes, J.J. Thistlethwaite, and J.K. Stuart Reexposure to OKT3 in renal allograft recipients Transplantation 45 1988 349 353
9. R.B. Ettenger Antibody therapy as an induction regimen in pediatric renal transplantation Transplant Proc 31 1999 2677 2678
10. D.C. Brennan, K. Flavin, and J.A. Lowell A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients Transplantation 67 1999 1011 1018
11. D.C. Brennan, J.A. Flavin, and J.A. Lowell Leukocyte response to Thymoglobulin or Atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients Transplant Proc 31 1999 16S 18S
12. L. Bell, C. Girardin, and A. Sharma Lymphocyte subsets during and after rabbit anti-thymocyte globulin induction in pediatric renal transplantation: sustained T cell depletion Transplant Proc 29 1997 6S 9S
13. B. Nashan, R. Moore, and P.L. Amlot Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients Lancet 350 1997 1193 1198
14. B.D. Kahan, P.R. Rajagopalan, and M.I. Hall Reduction of the occurrence of acute cellular rejection among allograft recipients treated with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody Transplantation 67 1999 276 284
15. G.L. Bumgardner, I. Hardie, R.W. Johnson Phase III Daclizumab Study Group Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation Transplantation 72 5 2001 839 845
16. B. Nashan, S. Light, and I.R. Hardie Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group Transplantation 67 1999 110 115
17. F. Vincenti, R. Kirkman, and S. Light Interleukin-2-receptor blockade with daclizumab to prevent rejection in renal transplantation N Engl J Med 338 1998 1700 1701
18. R. Ettenger, D. Potter, and M. Peskovitz Humanized monoclonal anti-interleukin-2 receptor (IL-2R) antibody daclizumab in pediatric renal transplantation Transplantation 65 1998 S16
19. M. Benfield, A. Tejani, and H. Ping-Leung Comparative study of the safety, efficacy, and practice patterns of monoclonal antibodies in pediatric renal transplantation Am J Transplant 2 Suppl 3 2002 S192
20. A.M. Krensky, and C. Clayberger Transplantation immunology Clin Immunol 41 1994 819 839
21. D. Ellis, R. Shapiro, and M.L. Jordan Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation Pediatr Nephrol 8 1994 193 200
22. F.J. Dumont, M.J. Staruch, and S.L. Koprach The immunosuppressive and toxic effects of FK 506 are mechanistically related: pharmacology of a novel antagonism of FK 506 and rapamycin J Exp Med 176 1992 751 760
23. W.L. Baeder, and L.M. Adams Effect of rapamycin, cyclosporin A, and prednisolone on murine thymocyte proliferation in vitro 1989 Wyeth-Ayerst Research Philadelphia (PA) [Publication #GTR-18812]
24. A.K. Khanna Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus Transplantation 70 4 2000 690 694
25. N. Orta-Sibu, C. Chantler, and M. Bewick Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children BMJ 285 1982 258 260
26. L. Chan, R. Gaston, and S. Hariharan Evolution of immunosuppression and continued importance of acute rejection in renal transplantation Am J Kidney Dis 38 6 Suppl 6 2001 S2 S9
27. V.R. Dharnidharka, D.M. Stablein, and W.E. Harmon Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS Am J Transplant 4 3 2004 384 389
28. G.H. Bock, E.K. Sullivan, and D. Miller Cytomegalovirus infections following renal transplantation-effects on antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study Group Pediatr Nephrol 11 6 1997 665 671
29. P.L. Hibberd, N.E. Tolkoff-Rubin, and A.B. Cosimi Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3 Transplantation 53 1992 68 72
30. P.L. Hibberd, N.E. Tolkoff-Rubin, and D. Conti Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients Ann Intern Med 123 1995 18 26
31. T.H. The, A.P. Vanden Bern, and W.J. van Son Monitoring for cytomegalovirus after organ transplantation: a clinical perspective Transplant Proc 25 1993 5 9
32. S.M. Flechner, R.K. Avery, and R. Fisher Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture Transplant Proc 31 1-2 1999 1255 1257
33. S.L. Furth, E.K. Sullivan, and A.M. Neu Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study Pediatr Transplant 1 1997 37 42
34. C.M. Feldoff, H.H. Balfour, and R.L. Simmon Varicella in children with renal transplants J Pediatr 98 1981 25 31
35. R. Lynfield, J.T. Herrin, and R.H. Rubin Varicella in pediatric renal transplant recipients Pediatrics 90 1992 216 220
36. M. Broyer, M.J. Tete, and G. Guest Varicella and zoster in children after kidney transplantation: long term results of vaccination Pediatrics 99 1 1997 35 39
37. C.E. Kashtan, M. Cook, and B.M. Chavers Outcome of chickenpox in 66 pediatric renal transplant recipients J Pediatr 131 6 1997 874 877
38. D.T. Purtilo, R.S. Strobach, and M. Okano Epstein-Barr virus-associated lymphoproliferative disorders Lab Invest 67 1992 5 23
39. V.R. Dharnidharka, E.K. Sullivan, and D.M. Stablein Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Transplantation 71 8 2001 1065 1068
40. S.M. Cockfield, J.K. Preiksaitis, and L.D. Jewell Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center Transplantation 56 1993 88 96
41. A. Fischer, S. Blanche, and J. Le Bidois Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation N Engl J Med 324 1994 1451 1456
42. D.T. Nguyen, J.A. Amess, and H. Doughty IDEC-C2B8 anti-CD (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients Eur J Hematol 62 2 1999 76 82
43. R.S. Shapiro, A. Chauvenet, and W. McGuire Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin N Engl J Med 330 1994 1334
44. E.B. Papadopoulos, M. Ladanyi, and D. Emanuel Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1994 1185 1191
45. A.R. Khann, S. Bell, and M. Sherritt Activation and adoptive transfer of Epstein Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease Proc Natl Acad Sci USA 96 18 1999 10391 10396
46. M.A. Nalesnik, A.S. Rao, and H. Furukawa Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients Transplantation 63 9 1997 1200 1205
47. P.K. Li, K. Tsang, and C.C. Szeto Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy Am J Kidney Dis 32 5 1998 813 819
48. G. Melosky, M. Karim, and A. Chui Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression J Am Soc Nephrol 2 1992 S290 S294
49. R.T. Schweizer, M. Rovelli, and D. Palmeri Noncompliance in organ transplant recipients Transplantation 49 1990 374 377
50. B.Z. Morgenstern, M. Murphy, and J. Dayton Noncompliance in a pediatric renal transplant population Transplant Proc 26 1994 129
51. K.E. Meyers, H. Weiland, and P.D. Thomson Pediatric renal transplantation noncompliance Pediatr Nephrol 9 1995 189 192
52. R.B. Ettenger, J.T. Rosenthal, and J.L. Marik Improved cadaveric renal transplant outcome in children Pediatr Nephrol 5 1991 137 142
53. D.E. Beck, R.S. Fennell, and R.L. Yost Evaluations of an educational program on compliance with medication regimens in pediatric patients with renal transplants J Pediatr 96 1980 1094 1097
54. K.E. Meyers, P.D. Thomson, and H. Weiland Noncompliance in children and adolescents after renal transplantation Transplantation 62 1996 186 189
55. B.R. Cole Noncompliance to medical regimens A.H. Tejani R.N. Fine Pediatric renal transplantation 1994 Wiley-Liss New York 397 445
56. T.E. Bunchman Compliance in pediatric transplant Pediatr Transplant 4 2000 165 169
57. L. Penkower, M.A. Dew, and D. Ellis Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients Am J Transplant 3 11 2003 1418 1425
58. E.G. Siegel, J.D. Mahan, and R.S. Johnson Solid organ transplantation in adolescents: the blessing and the curse Adolesc Med 5 1994 293 310
59. P.T. McEnery, D.M. Stablein, and G. Arbus Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study N Engl J Med 326 1992 1727 1732
60. K. Jabs, K. Sullivan, and E.D. Avner Alternate day steroid dosing improves growth without adversely affecting graft survival or long-term graft function Transplantation 61 1996 31 36
61. R. van Diemen-Steenvoorde, R.A. Donckerwolcke, and H. Brackel Growth and sexual maturation in children after kidney transplantation J Pediatr 110 3 1987 351 356
62. J.H. Kim, C.J. Chun, and C.M. Kang Kidney transplantation and menstrual changes Transplant Proc 30 7 1998 3057 3059
63. G. Deray, P. le Hoang, and P. Cacoub Oral contraceptive interaction with cyclosporin Lancet 1 8525 1987 158 159
64. B. Brouhard, K. Donaldson, and K. Lawry Qualiry of life of children post transplantation compared to children on dialysis. For the North American Pediatric Renal Transplant Cooperative Study Pediatr Transplant 2 Suppl 1 1998 80
65. R.S. Fennell, E.B. Fennell, and R.L. Carter A longitudinal study of the cognitive function of children with renal failure Pediatr Nephrol 4 1990 11 15
66. K.W. Lawry, B.H. Brouhard, and R.J. Cunningham Cognitive functioning and school performance in children with renal failure Pediatr Nephrol 8 1994 326 329